# Page 1
In this financial year 2024-25, Inj.
Centhaquine Citrate 1.0 mg
regarding administrative approval of the purchase.
Government of Maharashtra
Department of Public Health
Government Decision No: PASHAMA-1224 / P.No.41 / HEALTH-8
10th Floor, GoT Hospital Complex Building,
New Mantralaya, Mumbai - 400001.
Date: 12th June, 2024
Read: -
(1) Letter from the Joint Director, Health Services (Hospitals-State Level), Mumbai No. By / Room-3 / T-4 /
Nastie No. 19 / Visanseru Amravati Nashik / Inj. Centhaquin Citrate 1.0mg/2024/2921-23, d. 28.02.2024.
(2) Letter from the Joint Director, Health Services (Hospitals-State Level), Mumbai No. By / Room-3 / T-4 /
Supplementary / 225104259 / Inj.Centhaquin Citrate 1.0mg/11126-28, d. 10.05.2024
(3) Gazette, No. SDL2019 / Q. No. 181 / Health-8, D 29.12.2023
The Proposal: -
Divisional Reference Service Hospital, Amravati and Nashik offices in IUC.
Inj, which is essential. Centhaquine Citrate 1.0 mg is an emergency medication.
A demand has been registered for the supply of the drug in the number of 500. Intensive care of this drug
According to the feedback given by the Expert Committee on Use, Quality in the Department, Inj. Centhaquine Citrate 1.0
Government letter dated 29 for inclusion of mg in SDL (State Drug List)
Approval is due by December 2023. Accordingly, the Divisional Reference Service Hospitals
According to the demand made, in this financial year 2024-25 Inj. Centhaquine Citrate is 1.0 mg.
To the proposal submitted by the Commissionerate of Health Services under the reference letter for the purchase of the drug.
The issue of granting administrative approval is under the consideration of the government.
The Government's Decisions:
Proposals submitted by Joint Director, Health Services (Hospitals - State Level), Mumbai
According to the Departmental Reference Services Hospital, Amravati, in this financial year 2024-25
For the Inj. Centhaquine Citrate 1.0 mg is available for purchase at Rs. 49,25,000 - (character
The offer for an amount of Rs. Ninety-nine lakh twenty-five thousand only) is invited through Paragraph No. 03 is as follows:
Administrative approval is being granted subject to the conditions mentioned. For this purchase
The statement is as follows.
# Page 2
Government Decision No: PASHAMA-1224 / P.No.41 / HEALTH-8
Statement-A
Details of the grant
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Account Header                                                                                                                                                                                                                                                                                                          | Purchase Details                 | The amount of administrative approval | Available funds                                                              |
| Demand No.3 2210, Medical Services and Public Health, (09) Maharashtra Medical Commodities Procurement Authority, (09) (01) Procurement of Drugs, Pharmaceuticals, Machinery and Equipment through Maharashtra Medical Commodities Procurement Authority (Compulsory) 31 - Subsidiary Grants (Non-Payment) (2210 K 079) | Inj. Centhaquine Citrate 1. 0 mg | Rs. 49,25,000 Sun-                    | Provision made available through budgetary / supplementary demand in 2024-25 |
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Statement-B
Purchase Details
--------------------------------------------------------------------------------------------------------------------------------------------------------------------
| A. No | The name of the hospital                        | Details of the purchase          | Estimated rate | The number of approved | The amount of expenditure |
| 1     | Divisional Reference Service Hospital, Amravati | Inj. Centhaquine Citrate 1. 0 mg | Rs.9850 / -    | 500                    | Rs. 49,25,000 -           |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------
The Commissioner, Commissionerate of Health Services, Mumbai has been concerned with this proposal.
The manufacturer issued a letter dated 09.04.2024 to Inj. Centhaquine Citrate is 1.0 mg.
A proprietary article certificate that the company owns the drug; and
The Patent Certificate (Patent Number 282155) has been submitted along with the proposal. According to the main
The Executive Officer, Maharashtra Medical Supplies Procurement Authority, Mumbai, in. Centhaquine Citrate
The Department of Industry, Power and Labour Government Decision dated 01/12/2016 in Paragraph No.
3.2.6 Procurement operations should be carried out directly in a "single source" mode.
Commissioner, Health Services Commissionerate, Mumbai and CEO, Maharashtra.
The Medical Commodities Procurement Authority, Mumbai, while conducting the procurement / disposition of such drugs, is as follows:
Comply with the terms / conditions.
(1) Only after the need and demand for such medicine has been discerned / verified shall the
A tender process should be carried out for the purchase of items.
(2) It shall be ensured that the prescription of such drug is as required and up to date. Purchase
Technical Specification of matters to be done by the concerned experts (Technical Committee /
officer) should be in accordance with the direction agreed upon. Also, the technical
Page 2 of 4
# Page 3
Government Decision No: PASHAMA-1224 / P.No.41 / HEALTH-8
specification) designed in such a way that it would benefit any particular company.
Procurement of these items should be processed only after confirmation of non-existence.
(3) The decision of the Government by the Chief Executive Officer, Maharashtra Medical Supplies Procurement Authority, Mumbai,
Department of Industries, Power and Labour, No.Bhankhas-2014 / No.82 / Part-III / Industries-4, dated 1
Offices to be conducted by Government Departments notified as on December, 2016
in the prescribed manner as provided in the Revised Manual of Procedure for Procurement.
The purchase process should be carried out. Also Government Decisions, Finance Department, No. Vyapra-
2013 / Q. No.30 / Part-Financial in Annexure with the 2/2013 Regulations, dated 17th April, 2015
Rights Rulebook 1978, Part-I Sub-Division-II No. 4 Rule No. 7 in front of the
Column No. 6 The conditions here must be met.
(4) The proposed purchase rates are estimated at the time of administrative approval. So the price at the end of the purchase process
to be determined. The rate is less than the market price and is related to
The rate at which the supplier has supplied the item elsewhere is higher than the rate at which the supplier has supplied the item.
Be sure not to.
(5) Pre / Post-Dispatch Sample Inspection of items to be purchased
Random sample inspection only for items with proper and appropriate specifications.
Be sure to make a purchase.
(6) Central Vigilance Commission (CVC) guidelines while implementing the entire procurement process.
It should be followed strictly.
(7) Storage and distribution of items to be purchased after supply.
distribution, as well as supply chain management, and
Inventory management is done in a proper manner and these things go unutilized.
The Medical Superintendent concerned shall ensure that they do not remain and are used within the prescribed time frame.
should be taken.
(8) Ensure that the said purchase is completed within the prescribed period of administrative approval. As well as, or
Care should be taken that there is no duplication in the purchase of items. such a purchase.
Accordingly, after the completion of the tendering process, the details will be shared with the CEO, Maharashtra.
The Medical Supplies Procurement Authority, Mumbai should submit it to the government.
(9) The cost of this work, "Demand No. 3,2210, Medical Services and Public Health, (09) Maharashtra
Medical Commodities Procurement Authority, (09) (01) Drugs through Maharashtra Medical Commodities Procurement Authority,
Procurement of Pharmaceuticals, Machinery and Equipment (Mandatory) 31 - Subsidiary Grants-in-aid
(2210K 079) "approved in the financial year 2024-25 under the head"
Page 3 of 4
# Page 4
Government Decision No: PASHAMA-1224 / P.No.41 / HEALTH-8
Subsidised by the provision made available by the Supplementary Demand under the head
Expenses have to be paid.
(10) the fulfillment of the conditions mentioned above in serial numbers 1 to 09 and in accordance with the rules of purchase and
The Commissioner, Health Services, has full responsibility for ensuring that the requirement is met.
Commissionerate, Mumbai, CEO, Maharashtra Medical Supplies Procurement Authority, Mumbai and
The Joint Director will be from Health Services (Hospitals - State Level), Mumbai.
Government Decisions, Department of Finance, No.2013 / No. 30/13 Regulations, Part-II, dated
Financial Rights Manual 1978 Part-I Sub-section-II dated 17th April, 2015
Article No. 4, Rule No. Under 7, to purchase tools, retail equipment, and activity sets.
Full powers have been delegated to the administrative department for approval.
5. This Government decision is indicative of the Government of Maharashtra's www.maharashtra.gov.in